Next we found that fisetin treatment resulted in inhibition of mTOR and induction of autophagy, leading to preclinical alleviation of IMQ-induced psoriasis-like skin inflammation, skin thickness and scaling (Figure 6). The gene discussed is MTOR; the disease is dermatitis.